Associate Professor of Medicine at Duke University School of Medicine
Current relationship
Adam David DeVore is a Duke cardiologist whose work links advanced heart-failure care, transplantation, pragmatic clinical trials, and implementation research. He is an Associate Professor of Medicine at Duke University School of Medicine, a member of the Duke Clinical Research Institute, and medical director of the Duke Heart Transplant program. His clinical interests include patients with heart failure, left ventricular assist devices, and heart transplants. After earning his M.D. from the University of Chicago in 2007, he completed internal medicine residency at Brigham and Women’s Hospital from 2007 to 2010, cardiovascular medicine fellowship at Duke from 2011 to 2013, clinical research fellowship at DCRI from 2013 to 2015, and advanced heart failure fellowship at Duke from 2015 to 2016. He led CONNECT-HF and has served on steering committees for major heart-failure trials.
Married with 4 children and coaches youth baseball
Each topic is linked to its supporting source in Sources.
Training includes Fellowship in Advanced Heart Failure at Duke University School of Medicine, Fellowship in Clinical Research at the Duke Clinical Research Institute, Duke University School of Medicine, Fellowship in Cardiovascular Medicine at Duke University School of Medicine, and Internal medicine residency at Brigham and Women's Hospital, plus 4 more records.
Explore education and trainingAs of 2021
As of 2021
As of 2016
As of 2015
As of 2013
As of 2010
As of 2007
Involved in and leads multiple large heart failure studies at Duke University Medical Center and the Duke Clinical Research Institute[7]
Publication: Antibody-Mediated Rejection (Without the Antibodies) in Heart Transplantation[7]
2026
Publication: Coronary Evaluation of Donor Hearts in the Donation After Circulatory Death Era[7]
2026
Publication: Donor-Derived Cell-Free DNA as a Prognostic Biomarker After Heart Transplantation: The DEFINE-HT Study[7]
2026
Publication: Donor Heart Preservation at 10 °C Outperforms 4-8 °C With Improved Early Graft Function in Adult Heart Transplantation: A Vanderbilt and Duke Multicenter Study[7]
2026
Publication: Improving Heart Transplantation by Expanding the Donor Pool[11]
2021
Publication: Lost to Follow-Up in Pragmatic Trials With Remote Follow-Up: Insights From CONNECT-HF and TRANSFORM-HF[7]
2026
Publication: Microaxial Flow Pumps in Heart Failure-Related Cardiogenic Shock-From Hemodynamic Mechanisms to Clinical Applications: A State-of-the-Art Review[7]
2026
Publication: Organ-specific differences in the epidemiology of cytomegalovirus infections in high-risk solid organ transplant recipients with prolonged follow-up: A 10-year experience[7]
2026
Publication: Outcomes among patients bridged to heart transplant with microaxial flow versus durable left ventricular assist device support[7]
2026
Publication: Out-of-Sequence Donor Heart Allocation: A United Network for Organ Sharing Registry Analysis[7]
2026
Publication: Remote digital intervention targeting heart failure medical therapy: a randomized controlled trial[7]
2026
Published the first clinical trial conducted within the American Heart Association Get With The Guidelines-Heart Failure program, a registry-based cluster randomized trial of quality improvement interventions[7]
Research focuses on advancing understanding of heart failure through clinical trials and implementation strategies[7]